October 1, 2025 — Eric Maus
Rather than adopting MFN, the administration and Congress should reject price controls, reform 340B, and eliminate CMMI
October 1, 2025 — Eric Maus 1759353101
SB 198 would change how the federal 340B Drug Discount Program operates in the Buckeye State.
HB 4878 would change how the federal 340B Drug Discount Program operates in Michigan.
340B Patients Act would worsen 340B abuses by enriching large hospitals and middlemen at the expense of the patients in need.
MFN policies harm innovation and raise costs; 340B reforms stop hospitals and pharmacies from profiting at patients' expense.
Vague 340B rules enable hospitals to exploit the program, profiting off patients and insurers while driving up drug costs.
Vague 340B rules enable hospitals to exploit the program, profiting off patients and insurers while driving up drug costs.
Large non-profit hospitals exploit tax breaks and federal programs, undermining charity care and distorting the healthcare market.
AB 1460 would change how the federal 340B Drug Pricing Program operates in the Golden State
CAGW Submits Comments to HHS and HRSA Regarding 340B Rebate Model Pilot Program
HRSA’s 340B Rebate Model Pilot Program is a positive step in the effort to reform a program that is failing to deliver benefits